Emiley Neudorfer
Family · Butler, PANPI 1699253062
Payments from drug & device makers
Across 328 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$919
- Novo Nordisk$735
- Lilly USA, LLC$608
- GSK$446
- Teva Pharmaceuticals USA, Inc.$327
- Novartis$230
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,25598%
- Education$1322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $919 |
| Novo Nordisk | 48 | $735 |
| Lilly USA, LLC | 38 | $608 |
| GSK | 27 | $446 |
| Teva Pharmaceuticals USA, Inc. | 13 | $327 |
| Novartis | 13 | $230 |
| AstraZeneca | 12 | $206 |
| Pfizer | 11 | $179 |
| Amgen | 9 | $161 |
| Abbott | 9 | $159 |
| Johnson & Johnson | 9 | $147 |
| Kowa Pharmaceuticals America, Inc. | 7 | $125 |
| Daiichi Sankyo Inc. | 7 | $118 |
| Boehringer Ingelheim | 7 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $113 |
| Phathom Pharmaceuticals, Inc. | 6 | $105 |
| Shield Therapeutics Inc | 5 | $84 |
| Merck | 6 | $83 |
| Astellas Pharma US Inc | 4 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Bayer | 4 | $69 |
| Exact Sciences | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Boston Scientific | 1 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Dexcom, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$5,387 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $63,469 |
| MounjaroTirzepatide | 31 | $32,008 |
| JardianceEmpagliflozin | 20 | $25,159 |
| TrulicityDulaglutide | 26 | $24,734 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $23,931 |
| MyrbetriqMirabegron | 36 | $18,536 |
| EliquisApixaban | 23 | $17,192 |
| Nurtec OdtRimegepant Sulfate | 15 | $15,231 |
| WegovySemaglutide | 11 | $14,231 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,782 |
| VoqueznaVonoprazan Fumarate | 11 | $10,761 |
| KerendiaFinerenone | 12 | $7,638 |
| Repatha SureclickEvolocumab | 11 | $5,876 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $4,477 |
| Fentanyl | 12 | $1,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $735 | $77,70065 claims |
| Lilly USA, LLCMounjaro, Trulicity | $608 | $56,74357 claims |
| PfizerEliquis, Nurtec Odt | $179 | $32,42438 claims |
| Boehringer IngelheimJardiance | $116 | $25,15920 claims |
| GSKTrelegy Ellipta | $446 | $23,93121 claims |
| Astellas Pharma US IncMyrbetriq | $73 | $18,53636 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere | $206 | $15,25928 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $105 | $10,76111 claims |
| BayerKerendia | $69 | $7,63812 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $1,00339 claims |
| AbbVieSynthroid | $919 | $76815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Butler
- Margaret SpingolaButler$19K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.